Targeted delivery of nutraceuticals derived from food for the treatment of obesity and its related complications

Food Chem. 2023 Aug 30:418:135980. doi: 10.1016/j.foodchem.2023.135980. Epub 2023 Mar 22.

Abstract

Nutraceuticals which are abundant in foods have attracted much attention due to their bioactive activities of anti-obesity, anti-hyperlipidemia and anti-atherosclerosis. Unfortunately, the poor bioavailability severely undermines their envisioned benefits. Therefore, there is an urgent need to develop suitable delivery systems to promote the benefits of their biological activity. Targeted drug delivery system (TDDS) is a novel drug delivery system that can selectively concentrate drugs on targets in the body, improve the bioavailability of agents and reduce side effects. This emerging drug delivery system provides a new strategy for the treatment of obesity with nutraceuticals and would be a promising alternative to be widely used in the food field. This review summarizes the recent studies on the application in the targeted delivery of nutraceuticals for treating obesity and its related complications, especially the available receptors and their corresponding ligands for TDDS and the evaluation methods of the targeting ability.

Keywords: Atherosclerosis; Evaluation methods; Nanocarriers; Nonalcoholic fatty liver disease; Phytochemicals; Targeted delivery.

Publication types

  • Review

MeSH terms

  • Dietary Supplements*
  • Drug Delivery Systems / methods
  • Humans
  • Obesity* / drug therapy